0 29 eps expected for national research corporation nrcia 2

$0.29 EPS Expected for National Research Corporation (NRCIA)

April 25, 2018 – By Dolores Ford

Investors sentiment decreased to 1.75 in Q4 2017. Its down 0.07, from 1.82 in 2017Q3. It fall, as 5 investors sold National Research Corporation shares while 19 reduced holdings. 15 funds opened positions while 27 raised stakes. 8.18 million shares or 35.51% more from 6.04 million shares in 2017Q3 were reported.

Wedge Cap Mngmt L Limited Partnership Nc reported 0% in National Research Corporation (NASDAQ:NRCIA). Jpmorgan Chase And Communication owns 2,297 shares or 0% of their US portfolio. Rhumbline Advisers stated it has 8,874 shares or 0% of all its holdings. Wells Fargo & Communications Mn has invested 0% in National Research Corporation (NASDAQ:NRCIA). Massachusetts-based Panagora Asset Mngmt Inc has invested 0% in National Research Corporation (NASDAQ:NRCIA). Parallax Volatility Advisers L P stated it has 0% in National Research Corporation (NASDAQ:NRCIA). Northern Trust Corp accumulated 143,290 shares or 0% of the stock. Sei Invs has 1,043 shares. 289,900 are owned by Renaissance Technologies Limited Liability Company. California State Teachers Retirement stated it has 0% in National Research Corporation (NASDAQ:NRCIA). Fincl Bank Of Ny Mellon Corporation invested in 96,449 shares. Geode Mgmt holds 92,696 shares or 0% of its portfolio. Ohio-based Meeder Asset Mgmt has invested 0% in National Research Corporation (NASDAQ:NRCIA). California-based First Quadrant L P Ca has invested 0.01% in National Research Corporation (NASDAQ:NRCIA). Bank Of America Corp De reported 4,876 shares.

Since January 25, 2018, it had 1 insider purchase, and 9 insider sales for $58.65 million activity. Hays Michael D. sold $101.60M worth of National Research Corporation (NASDAQ:NRCIA) on Thursday, February 15. Amandla MK Trust also bought $106.10M worth of National Research Corporation (NASDAQ:NRCIA) shares.

Analysts expect National Research Corporation (NASDAQ:NRCIA) to report $0.29 EPS on May, 1.They anticipate $0.03 EPS change or 11.54 % from last quarter’s $0.26 EPS. NRCIA’s profit would be $7.69M giving it 28.92 P/E if the $0.29 EPS is correct. After having $0.10 EPS previously, National Research Corporation’s analysts see 190.00 % EPS growth. The stock increased 1.51% or $0.5 during the last trading session, reaching $33.55. About 36,816 shares traded or 55.47% up from the average. National Research Corporation (NASDAQ:NRCIA) has risen 44.75% since April 25, 2017 and is uptrending. It has outperformed by 33.20% the S&P500.

National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. The company has market cap of $889.27 million. The Company’s portfolio of subscription solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. It has a 37.2 P/E ratio. The firm offers Market Insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.

National Research Corporation (NASDAQ:NRCIA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Back To Top